SANTAMARIA, SARA
 Distribuzione geografica
Continente #
EU - Europa 754
AS - Asia 86
NA - Nord America 14
SA - Sud America 13
AF - Africa 1
OC - Oceania 1
Totale 869
Nazione #
IT - Italia 753
SG - Singapore 33
CN - Cina 24
VN - Vietnam 20
US - Stati Uniti d'America 13
BR - Brasile 8
HK - Hong Kong 3
ID - Indonesia 3
AR - Argentina 2
EC - Ecuador 2
BD - Bangladesh 1
CO - Colombia 1
MX - Messico 1
NC - Nuova Caledonia 1
NL - Olanda 1
PH - Filippine 1
UZ - Uzbekistan 1
ZA - Sudafrica 1
Totale 869
Città #
Genoa 466
Vado Ligure 116
Genova 90
Rapallo 62
Ashburn 12
Beijing 8
Singapore 7
Bordighera 6
Ho Chi Minh City 6
Rome 5
Hanoi 3
Hong Kong 3
Hải Dương 3
Milan 3
Ninh Bình 2
Bella Vista 1
Brugherio 1
Caieiras 1
Cape Town 1
Cayambe 1
Federal 1
Ferraz de Vasconcelos 1
Florianópolis 1
Fortaleza 1
Haiphong 1
Juiz de Fora 1
Kennedy 1
Macapá 1
Manado 1
Manila 1
Mexico City 1
Noumea 1
Phủ Lý 1
Quito 1
Quận Năm 1
Samarinda 1
São Paulo 1
Tashkent 1
Turin 1
Vila Velha 1
Việt Hưng 1
Totale 818
Nome #
Berberine affects mitochondrial activity and cell growth of leukemic cells from chronic lymphocytic leukemia patients 131
Comprehensive profiling of secretome formulations from fetal-and perinatal human amniotic fluid stem cells 117
Dissecting the effects of preconditioning with inflammatory cytokines and hypoxia on the angiogenic potential of mesenchymal stromal cell (MSC)-derived soluble proteins and extracellular vesicles (EVs) 112
Front-line liquid biopsy for early molecular assessment and treatment of hospitalized lung cancer patients 92
Trastuzumab Modulates the Protein Cargo of Extracellular Vesicles Released by ERBB2+ Breast Cancer Cells 89
Stimulation of synaptic activity promotes TFEB-mediated clearance of pathological MAPT/Tau in cellular and mouse models of tauopathies 68
Imaging of Endocytic Trafficking and Extracellular Vesicles Released Under Neratinib Treatment in ERBB2+ Breast Cancer Cells 67
Extracellular vesicles miR-574-5p and miR-181a-5p as prognostic markers in NSCLC patients treated with nivolumab 63
ERBB2-target therapies in breast cancer: Investigating the biological mechanisms regulated by the pan-ERBB inhibitor Neratinib 59
Neratinib is a TFEB and TFE3 activator that potentiates autophagy and unbalances energy metabolism in ERBB2+ breast cancer cells 54
Refining Flow Cytometry-based Sorting of Plasma-derived Extracellular Vesicles 23
Immune Checkpoint Inhibitors and Targeted Therapies in Early-Stage Non-Small-Cell Lung Cancer: State-of-the-Art and Future Perspectives 12
Identification of prognostic liquid biopsy biomarkers in patients with cutaneous squamous cell carcinoma treated with cemiplimab 8
Totale 895
Categoria #
all - tutte 4.088
article - articoli 3.760
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.848


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202125 0 0 0 0 0 0 0 5 5 12 1 2
2021/202266 4 7 1 7 6 0 4 15 0 9 3 10
2022/202377 6 9 0 6 7 10 0 3 17 5 14 0
2023/202495 7 4 4 12 13 15 7 10 4 3 4 12
2024/2025344 12 12 8 30 27 39 33 63 20 22 42 36
2025/2026283 58 23 30 63 97 12 0 0 0 0 0 0
Totale 895